Blake Borgeson Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Blake Borgeson is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 7.07 Million shares of RXRX, which is worth approximately $40.3 Million. The most recent transaction as insider was on Nov 12, 2024, when has been sold 11,447 shares (Class A Common Stock) at a price of $7.64 per share, resulting in proceeds of $87,455. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.07M

0.93% 3M change

4.61% 12M change

Total Value Held $40.3 Million

Blake Borgeson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 12 2024	SELL Open market or private sale	$87,455 $7.64 p/Share	11,447 Reduced 0.16%	7,066,113 Class A Common Stock
Oct 29 2024	SELL Open market or private sale	$76,923 $6.72 p/Share	11,447 Reduced 0.16%	7,077,560 Class A Common Stock
Oct 15 2024	SELL Open market or private sale	$76,351 $6.67 p/Share	11,447 Reduced 0.16%	7,089,007 Class A Common Stock
Oct 01 2024	SELL Open market or private sale	$71,200 $6.22 p/Share	11,447 Reduced 0.16%	7,098,428 Class A Common Stock
Oct 01 2024	BUY Grant, award, or other acquisition	-	2,026 Added 0.03%	7,100,454 Class A Common Stock
Sep 17 2024	SELL Open market or private sale	$78,297 $6.84 p/Share	11,447 Reduced 0.16%	7,109,875 Class A Common Stock
Sep 03 2024	SELL Open market or private sale	$71,772 $6.27 p/Share	11,447 Reduced 0.16%	7,121,322 Class A Common Stock
Aug 20 2024	SELL Open market or private sale	$81,502 $7.12 p/Share	11,447 Reduced 0.16%	7,132,769 Class A Common Stock
Aug 06 2024	SELL Open market or private sale	$78,068 $6.82 p/Share	11,447 Reduced 0.16%	7,144,216 Class A Common Stock
Jul 23 2024	SELL Open market or private sale	$97,070 $8.48 p/Share	11,447 Reduced 0.16%	7,155,663 Class A Common Stock
Jul 09 2024	SELL Open market or private sale	$83,792 $7.32 p/Share	11,447 Reduced 0.16%	7,167,110 Class A Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	-	1,441 Added 0.02%	7,178,557 Class A Common Stock
Jun 25 2024	SELL Open market or private sale	$108,860 $9.51 p/Share	11,447 Reduced 0.16%	7,177,116 Class A Common Stock
Jun 11 2024	SELL Open market or private sale	$96,727 $8.45 p/Share	11,447 Reduced 0.16%	7,188,563 Class A Common Stock
Jun 03 2024	BUY Grant, award, or other acquisition	-	13,097 Added 0.18%	7,200,010 Class A Common Stock
May 28 2024	SELL Open market or private sale	$104,968 $9.17 p/Share	11,447 Reduced 0.16%	7,186,913 Class A Common Stock
May 14 2024	SELL Open market or private sale	$202,946 $10.12 p/Share	20,054 Reduced 0.28%	7,198,360 Class A Common Stock
Apr 30 2024	SELL Open market or private sale	$91,003 $7.95 p/Share	11,447 Reduced 0.16%	7,218,414 Class A Common Stock
Apr 16 2024	SELL Open market or private sale	$87,684 $7.66 p/Share	11,447 Reduced 0.16%	7,229,861 Class A Common Stock
Apr 02 2024	SELL Open market or private sale	$100,962 $8.82 p/Share	11,447 Reduced 0.16%	7,241,308 Class A Common Stock
Mar 19 2024	SELL Open market or private sale	$216,382 $10.79 p/Share	20,054 Reduced 0.28%	7,252,755 Class A Common Stock
Mar 05 2024	SELL Open market or private sale	$241,851 $12.06 p/Share	20,054 Reduced 0.27%	7,272,809 Class A Common Stock
Feb 20 2024	SELL Open market or private sale	$254,284 $12.68 p/Share	20,054 Reduced 0.27%	7,292,863 Class A Common Stock
Feb 06 2024	SELL Open market or private sale	$106,457 $9.3 p/Share	11,447 Reduced 0.16%	7,312,917 Class A Common Stock
Jan 23 2024	SELL Open market or private sale	$212,171 $10.58 p/Share	20,054 Reduced 0.27%	7,324,364 Class A Common Stock

Blake Borgeson

Director

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX

Account